Stockreport

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results [Yahoo! Finance]

Kronos Bio, Inc.  (KRON) 
PDF IND-enabling studies for KB-9558 expected to complete in 2024 with first-in-human study anticipated to commence in the first half of 2025 $175.0 million in cash, cash [Read more]